179 related articles for article (PubMed ID: 35533195)
21. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
22. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
23. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Hartman AL; Ling L; Nichol ST; Hibberd ML
J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
[TBL] [Abstract][Full Text] [Related]
24. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
25. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
[TBL] [Abstract][Full Text] [Related]
26. Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association.
Zhu L; Gao T; Huang Y; Jin J; Wang D; Zhang L; Jin Y; Li P; Hu Y; Wu Y; Liu H; Dong Q; Wang G; Zheng T; Song C; Bai Y; Zhang X; Liu Y; Yang W; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Xiao G; Liu X; Cao C
Nat Commun; 2022 Apr; 13(1):2256. PubMed ID: 35474062
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
Biedenkopf N; Lier C; Becker S
J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
[TBL] [Abstract][Full Text] [Related]
28. Structures of Ebola and Reston Virus VP35 Oligomerization Domains and Comparative Biophysical Characterization in All Ebolavirus Species.
Zinzula L; Nagy I; Orsini M; Weyher-Stingl E; Bracher A; Baumeister W
Structure; 2019 Jan; 27(1):39-54.e6. PubMed ID: 30482729
[TBL] [Abstract][Full Text] [Related]
29. Disruption of Ebola NP
Wu C; Wagner ND; Moyle AB; Feng A; Sharma N; Stubbs SH; Donahue C; Davey RA; Gross ML; Leung DW; Amarasinghe GK
J Mol Biol; 2023 Oct; 435(20):168241. PubMed ID: 37598728
[TBL] [Abstract][Full Text] [Related]
30. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
[TBL] [Abstract][Full Text] [Related]
31. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.
Seesuay W; Jittavisutthikul S; Sae-Lim N; Sookrung N; Sakolvaree Y; Chaicumpa W
Emerg Microbes Infect; 2018 Mar; 7(1):41. PubMed ID: 29568066
[TBL] [Abstract][Full Text] [Related]
32. Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport.
Takamatsu Y; Yoshikawa T; Kurosu T; Fukushi S; Nagata N; Shimojima M; Ebihara H; Saijo M; Noda T
J Virol; 2022 Sep; 96(17):e0108322. PubMed ID: 35993739
[TBL] [Abstract][Full Text] [Related]
33. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
34. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription.
Ivanov A; Ramanathan P; Parry C; Ilinykh PA; Lin X; Petukhov M; Obukhov Y; Ammosova T; Amarasinghe GK; Bukreyev A; Nekhai S
Cell Mol Life Sci; 2020 Jul; 77(13):2579-2603. PubMed ID: 31562565
[TBL] [Abstract][Full Text] [Related]
35. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
36. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
Yen B; Mulder LC; Martinez O; Basler CF
J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
[TBL] [Abstract][Full Text] [Related]
38. Ebola Virus VP35 Interacts Non-Covalently with Ubiquitin Chains to Promote Viral Replication Creating New Therapeutic Opportunities.
Rodríguez-Salazar CA; van Tol S; Mailhot O; Galdino G; Teruel N; Zhang L; Warren AN; González-Orozco M; Freiberg AN; Najmanovich RJ; Giraldo MI; Rajsbaum R
bioRxiv; 2023 Jul; ():. PubMed ID: 37503276
[TBL] [Abstract][Full Text] [Related]
39. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of human LC8 bound to a peptide from Ebola virus VP35.
Lim D; Shin HC; Choi JS; Kim SJ; Ku B
J Microbiol; 2021 Apr; 59(4):410-416. PubMed ID: 33630249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
